文献速递心肺康复

间质性肺疾病特异性测量工具在运动干预中的测量性能:系统综述

Interstitial lung diseases specific measures in exercise interventions: A systematic review of measurement properties.
PubMed 文献 · Ann Phys Rehabil Med · 2022-11-30

该系统综述分两阶段:第一阶段识别运动干预研究中使用的间质性肺疾病(ILD)特异性结局测量工具,仅发现圣乔治呼吸问卷-间质性肺纤维化版(SGRQ-IPF)被使用(n=2项试验);第二阶段评价12种工具的测量性能,内容效度、内部一致性、重测信度、假设检验和反应性证据充分,但测量误差证据不足,跨文化和结构效度不确定,证据质量多为极低至中等。

要点

  • 运动干预研究中ILD特异性测量工具使用极少,仅SGRQ-IPF被2项试验使用。
  • 12种工具的测量性能中,内容效度、内部一致性、重测信度、假设检验和反应性证据充分。
  • 测量误差证据不足,跨文化和结构效度不确定,证据质量多为极低至中等。

核心结论

  • ILD特异性结局测量工具在运动干预试验中使用不频繁,其测量性能信息稀缺。

研究设计与样本

  • 两阶段系统综述:第一阶段识别运动干预研究中使用的ILD特异性测量工具,第二阶段评价其测量性能。
  • 检索PubMed、Web of Science、Scopus、EBSCO和EMBASE至2021年3月。
  • 由1名评价者提取数据,2名评价者独立使用COSMIN推荐评估偏倚风险和测量性能质量。

主要发现

  • 第一阶段识别18条记录,SGRQ-IPF是唯一被使用的ILD特异性结局测量工具(n=2项试验)。
  • 第二阶段纳入31条合格记录,报告了12种测量工具的测量性能。
  • 测量工具在内容效度、内部一致性(Cronbach's alpha 0.61-0.96)、重测信度(组内相关系数0.39;0.96)、假设检验和反应性方面证据充分。
  • 测量误差证据不足,跨文化和结构效度不确定。
  • King简易间质性肺疾病问卷和SGRQ-IPF的测量性能充分证据高于其他工具,证据质量多为极低至中等。

关键数值与推荐

  • 内部一致性Cronbach's alpha范围为0.61-0.96。
  • 重测信度组内相关系数报告为0.39和0.96。
  • SGRQ-IPF是唯一在运动干预试验中使用的ILD特异性结局测量工具(n=2项试验)。
  • 12种测量工具报告了测量性能,证据质量多为极低至中等。

临床怎么用

  • 在ILD运动干预研究中可优先考虑King简易间质性肺疾病问卷和SGRQ-IPF,因其测量性能证据相对更充分。
  • 使用ILD特异性测量工具时需注意测量误差证据不足及跨文化、结构效度不确定的问题。
  • 解读相关研究结果时应考虑测量工具性能证据质量多为极低至中等。

局限性

  • 证据质量多为极低至中等。
  • 测量误差证据不足,跨文化和结构效度不确定。
  • ILD特异性测量工具在运动干预试验中使用不频繁,相关测量性能信息稀缺。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Effects of exercise-based interventions (EBIs) on people with interstitial lung disease (ILD) are not yet fully understood. Reasons may include the limited use of ILD-specific measures and/or the lack of adequate information regarding their measurement properties. The purpose of this review was to summarize the ILD-specific outcome measures used in EBI studies and their measurement properties. METHODS: This was a two-phase systematic review: phase 1 identified ILD-specific measures used in EBI studies; phase 2 reviewed their measurement properties. PubMed, Web of Science, Scopus, EBSCO and EMBASE were searched up to March 2021. One reviewer extracted data, and 2 reviewers independently assessed studies risk of bias as well as the quality of measurement properties using the Consensus-Based Standards for the Selection of Health Status Measurement Instruments (COSMIN) recommendations. RESULTS: Phase 1 identified 18 records. The St George's Respiratory Questionnaire for Interstitial Pulmonary Fibrosis (SGRQ-IPF) was the only ILD-specific outcome measure used (n = 2 trials). Phase 2 resulted in 31 eligible records; measurement properties were reported for 12 measures. Measures presented sufficient content validity, internal consistency (Cronbach's alpha 0.61-0.96), test-retest reliability (intraclass correlation coefficient 0.39; 0.96), hypothesis testing and responsiveness but were insufficient for measurement error and indeterminate for cross-cultural and structural validity. The outcome measures King's Brief Interstitial Lung Disease and SGRQ-IPF had higher evidence of adequate measurement properties than other measures. Quality of the evidence was mostly very low to moderate. CONCLUSIONS: ILD-specific outcome measures are used infrequently in EBI trials, and there is scarce information regarding their measurement properties. DATABASE REGISTRATION: CRD42018112466.

来源:Ann Phys Rehabil Med,查看原文。版权归原作者所有。

引用

  1. Oliveira A, Habash R, Ellerton L, et al. Interstitial lung diseases specific measures in exercise interventions: A systematic review of measurement properties. Ann Phys Rehabil Med. 2022. PMID: 35659584. doi:10.1016/j.rehab.2022.101682

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。